Zelira Therapeutics Ltd

G1G

Company Profile

  • Business description

    Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. The company is organised into two operating segments based on geographic location of operations: Australia and United States of America.

  • Contact

    101 St George’s Terrace
    Level 3
    PerthWA6000
    AUS

    T: +61 865580886

    https://www.zeliratx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    8

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,692.20144.40-1.63%
CAC 408,080.7466.09-0.81%
DAX 4025,463.81272.43-1.06%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,452.6898.49-0.93%
HKSE22,393.68447.94-1.96%
NASDAQ23,879.20550.69-2.25%
Nikkei 22556,775.042,669.17-4.49%
NZX 50 Index14,140.80106.45-0.75%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,592.40138.00-1.58%
SSE Composite Index3,515.3762.25-1.74%

Market Movers